Effective Desensitization in Fibromyalgia Using Continuous Intravenous Lidocaine and Ketamine Infusion: A Case Report
Nepal Medical Journal · 17.06.2026 · 9 (1) · 44-47
DOI: 10.37080/nmj.291 ↗Kurz gefasst
Fallbericht in der Zeitschrift Nepal Medical Journal, online erschienen am 17.06.2026. Verfasst von Kathana Panmei und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Fibromyalgia is a complex chronic disorder characterized by widespread musculoskeletal pain, fatigue, cognitive dysfunction, and sleep disturbances. The underlying pathophysiology remains incompletely understood. Conventional pharmacological therapies often provide limited symptom relief, necessitating the exploration of alternative treatment modalities. Ketamine and lidocaine, through N-methyl-D-aspartate (NMDA) receptor antagonism and sodium channel blockade, respectively, may provide synergistic analgesic effects. However, dosing protocols for these agents remain poorly standardized. Case Presentation: A 28-year-old woman with a 10-year history of fibromyalgia presented with diffuse musculoskeletal pain, fatigue, cognitive symptoms, and sleep disturbances. She fulfilled the 2016 American College of Rheumatology (ACR) diagnostic criteria for fibromyalgia. Following inadequate response to conventional pharmacological and non-pharmacological treatments, she underwent a series of intravenous ketamine and lidocaine infusions administered under close medical supervision. The doses were gradually titrated over five treatment sessions. The patient reported substantial improvements in pain intensity, sleep quality, and functional status. Additionally, her gabapentin dosage was successfully reduced.
Discussion
Combined intravenous ketamine and lidocaine infusion was associated with significant symptomatic and functional improvement in a patient with refractory fibromyalgia. The observed benefits support the potential role of this therapy in targeting central sensitization; however, further studies are required to confirm its long-term efficacy and safety.
Conclusion
This case demonstrates that combined intravenous ketamine and lidocaine infusions may effectively reduce symptoms associated with fibromyalgia and enhance functional outcomes. These findings support the need for further studies to establish standardized dosing protocols and evaluate long-term efficacy and safety.
Zitieren
APA
Panmei, K., & Amatya, S. P. (2026). Effective Desensitization in Fibromyalgia Using Continuous Intravenous Lidocaine and Ketamine Infusion: A Case Report. Nepal Medical Journal, 9(1), 44-47. https://doi.org/10.37080/nmj.291
Vancouver
Panmei K, Amatya SP. Effective Desensitization in Fibromyalgia Using Continuous Intravenous Lidocaine and Ketamine Infusion: A Case Report. Nepal Medical Journal. 2026;9(1):44-47. doi:10.37080/nmj.291
BibTeX
@article{Panmei2026,
author = {Panmei, Kathana and Amatya, Shirish Prasad},
title = {Effective Desensitization in Fibromyalgia Using Continuous Intravenous Lidocaine and Ketamine Infusion: A Case Report},
journal = {Nepal Medical Journal},
year = {2026},
volume = {9},
number = {1},
pages = {44--47},
doi = {10.37080/nmj.291}
}
EUVIMED